Imiquimod is a medication used to manage and treat anogenital warts, superficial basal cell carcinomas, and actinic keratoses. It is in the immune modulator class of drugs. This activity describes the indications, action, and contraindications for imiquimod as a valuable agent in treating anogenital warts, superficial basal cell carcinomas, and actinic keratoses. In addition, this activity will highlight the mechanism of action, adverse event profile, and other key factors, such as toxicity and monitoring, pertinent for members of the healthcare team in the management of patients with anogenital warts, superficial basal cell carcinomas, and actinic keratoses.

**Objectives:**
- Describe the indications of imiquimod.
- Identify the adverse effects of imiquimod.
- Review the mechanism of action of imiquimod.
- Summarize the importance of improving care coordination amongst the interprofessional team to improve outcomes for patients receiving imiquimod.